The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.

Abdullah Al-Sohaim,Abdullah Saleh Bawazir,Turki Al-Turki,Eiman Omar Alsafi,Abdullah Al-Roqy,Layla Layqah,Salim Alawi Baharoone

The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.

2021

Abdullah Al-Sohaim
Abdullah Saleh Bawazir
Turki Al-Turki
Eiman Omar Alsafi
Abdullah Al-Roqy
Layla Layqah
Salim Alawi Baharoone

BACKGROUND: Adalimumab is a fully humanized monoclonal antibody inhibitor of tumor necrosis factor-a used to treat various autoimmune disorders. Adalimumab poses a risk for tuberculosis (TB) infect...

Keywords:

Immunology
Tuberculosis
Adalimumab therapy
Monoclonal antibody
Tumor necrosis factor alpha
Adalimumab
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations